SG10202107533RA - Method of administering nitroxyl donating compounds - Google Patents
Method of administering nitroxyl donating compoundsInfo
- Publication number
- SG10202107533RA SG10202107533RA SG10202107533RA SG10202107533RA SG10202107533RA SG 10202107533R A SG10202107533R A SG 10202107533RA SG 10202107533R A SG10202107533R A SG 10202107533RA SG 10202107533R A SG10202107533R A SG 10202107533RA SG 10202107533R A SG10202107533R A SG 10202107533RA
- Authority
- SG
- Singapore
- Prior art keywords
- donating compounds
- nitroxyl donating
- administering nitroxyl
- administering
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical compound O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762441803P | 2017-01-03 | 2017-01-03 | |
| US201762549932P | 2017-08-24 | 2017-08-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202107533RA true SG10202107533RA (en) | 2021-08-30 |
Family
ID=61224497
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202107533RA SG10202107533RA (en) | 2017-01-03 | 2018-01-02 | Method of administering nitroxyl donating compounds |
| SG11201906145YA SG11201906145YA (en) | 2017-01-03 | 2018-01-02 | Method of administering nitroxyl donating compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201906145YA SG11201906145YA (en) | 2017-01-03 | 2018-01-02 | Method of administering nitroxyl donating compounds |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11083704B2 (https=) |
| EP (1) | EP3565544A1 (https=) |
| JP (1) | JP2020503356A (https=) |
| KR (1) | KR20190103281A (https=) |
| CN (1) | CN110520116A (https=) |
| AU (1) | AU2018205621B2 (https=) |
| BR (1) | BR112019013702A2 (https=) |
| CA (1) | CA3049003A1 (https=) |
| IL (1) | IL267728A (https=) |
| MX (1) | MX388684B (https=) |
| SG (2) | SG10202107533RA (https=) |
| WO (1) | WO2018128999A1 (https=) |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1024524A (en) | 1910-08-06 | 1912-04-30 | Lanston Monotype Machine Co | Type-casting machine. |
| US1058314A (en) | 1911-02-20 | 1913-04-08 | B F Cummins Company | Separating mechanism for mail-matter. |
| US1048704A (en) | 1911-04-29 | 1912-12-31 | King Construction Company | Clip for connecting rafters, purlins, and sash-bars of greenhouses. |
| US1017976A (en) | 1911-08-25 | 1912-02-20 | Rudolph Koch | Automatic mail-bag catcher and deliverer. |
| US1021340A (en) | 1911-10-14 | 1912-03-26 | William A Scott | Means for attaching binding-posts to dry batteries. |
| US1051784A (en) | 1912-02-16 | 1913-01-28 | Martin Trewhitt | Brooder. |
| US5998458A (en) * | 1997-06-25 | 1999-12-07 | University Technology Corporation | Method of treating heart failure |
| US20040038947A1 (en) | 2002-06-14 | 2004-02-26 | The Gov. Of The U.S. Of America As Represented By The Sec. Of The Dept. Of Health & Human Services | Method of treating ischemia/reperfusion injury with nitroxyl donors |
| US6936639B2 (en) | 2002-08-21 | 2005-08-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nitroxyl progenitors in the treatment of heart failure |
| CA2554771A1 (en) | 2004-01-30 | 2005-08-18 | Johns Hopkins University | Nitroxyl progenitor compounds and methods of use |
| EP1909779A1 (en) | 2005-06-23 | 2008-04-16 | Johns Hopkins University | Thiol-sensitive positive inotropes |
| BRPI0708804B8 (pt) | 2006-03-17 | 2021-05-25 | Cardioxyl Pharmaceuticals Inc | compostos derivados de n-hidroxilsulfonamida como doadores de nitroxil, composição farmacêutica e kit |
| EP2010476A4 (en) | 2006-04-13 | 2011-01-26 | Univ Wake Forest Health Sciences | NITROXYL DISPENSERS FROM C-NITROSO COMPOUNDS |
| NZ584036A (en) | 2007-09-26 | 2012-06-29 | Univ Johns Hopkins | N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| LT2278975T (lt) | 2008-05-07 | 2016-11-25 | Cardioxyl Pharmaceuticals Inc. | Nauji nitrozo junginiai kaip nitroksilo donorai, ir jų panaudojimo būdas |
| WO2011063339A1 (en) | 2009-11-23 | 2011-05-26 | Cardioxyl Pharmaceuticals, Inc. | Nitroxyl donors for the treatment of pulmonary hypertension |
| US20110144067A1 (en) | 2009-12-07 | 2011-06-16 | Toscano John P | N-Acyloxysulfonamide and N-Hydroxy-N-Acylsulfonamide Derivatives |
| WO2011071947A2 (en) | 2009-12-07 | 2011-06-16 | Johns Hopkins University | Bis-acylated hydroxylamine derivatives |
| AU2013201929B2 (en) | 2011-10-17 | 2015-07-23 | The Johns Hopkins University | N-substituted hydroxylamine derivatives with carbon-based leaving groups |
| WO2014070919A1 (en) | 2012-11-01 | 2014-05-08 | The Johns Hopkins University | Controlled hno release through intramolecular cyclization-elimination |
| HRP20180121T1 (hr) | 2013-01-18 | 2018-02-23 | Cardioxyl Pharmaceuticals Inc. | Donori nitroksila s poboljšanim terapijskim indeksom |
| EP2764868A1 (en) * | 2013-02-08 | 2014-08-13 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Combination of nitroprusside and a sulfide salt as an HNO-releasing therapeutic for the treatment or prevention of cardiovascular diseases |
| US20160008394A1 (en) * | 2013-02-28 | 2016-01-14 | Aires Pharmaceuticals, Inc. | Inorganic nitrite to improve cardiopulmonary hemodynamics |
| EP2833611A1 (en) | 2013-07-31 | 2015-02-04 | Airbus Operations GmbH | Method of transmitting speech and digital data via an analog speech channel |
| EP3126329B1 (en) | 2014-01-17 | 2019-05-29 | Cardioxyl Pharmaceuticals Inc. | N-hydroxymethanesulfonamide nitroxyl donors |
| US9464061B2 (en) | 2014-05-27 | 2016-10-11 | The Johns Hopkins University | N-hydroxylamino-barbituric acid derivatives |
| EP3148972B1 (en) | 2014-05-27 | 2019-08-21 | Cardioxyl Pharmaceuticals, Inc. | Pyrazolone derivatives as nitroxyl donors |
| US10730828B2 (en) | 2015-10-19 | 2020-08-04 | Cardioxyl Pharmaceuticals, Inc. | N-hydroxylsulfonamide derivatives as nitroxyl donors |
| KR20180063326A (ko) | 2015-10-19 | 2018-06-11 | 카르디옥실 파마슈티칼스 인코포레이티드 | 니트록실 공여자로서의 피라졸론 유도체 |
| US10913728B2 (en) | 2016-07-28 | 2021-02-09 | The Johns Hopkins University | O-substituted hydroxamic acids |
-
2018
- 2018-01-02 US US16/475,672 patent/US11083704B2/en active Active
- 2018-01-02 SG SG10202107533RA patent/SG10202107533RA/en unknown
- 2018-01-02 AU AU2018205621A patent/AU2018205621B2/en active Active
- 2018-01-02 MX MX2019008000A patent/MX388684B/es unknown
- 2018-01-02 BR BR112019013702-5A patent/BR112019013702A2/pt not_active Application Discontinuation
- 2018-01-02 EP EP18705193.3A patent/EP3565544A1/en not_active Withdrawn
- 2018-01-02 CA CA3049003A patent/CA3049003A1/en active Pending
- 2018-01-02 KR KR1020197022537A patent/KR20190103281A/ko not_active Ceased
- 2018-01-02 SG SG11201906145YA patent/SG11201906145YA/en unknown
- 2018-01-02 WO PCT/US2018/012114 patent/WO2018128999A1/en not_active Ceased
- 2018-01-02 JP JP2019536215A patent/JP2020503356A/ja active Pending
- 2018-01-02 CN CN201880014677.7A patent/CN110520116A/zh active Pending
-
2019
- 2019-06-30 IL IL267728A patent/IL267728A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018205621B2 (en) | 2023-01-05 |
| IL267728A (en) | 2019-08-29 |
| MX2019008000A (es) | 2019-11-05 |
| US20190343790A1 (en) | 2019-11-14 |
| US11083704B2 (en) | 2021-08-10 |
| AU2018205621A1 (en) | 2019-08-01 |
| WO2018128999A1 (en) | 2018-07-12 |
| BR112019013702A2 (pt) | 2020-03-03 |
| SG11201906145YA (en) | 2019-08-27 |
| CN110520116A (zh) | 2019-11-29 |
| CA3049003A1 (en) | 2018-07-12 |
| MX388684B (es) | 2025-03-20 |
| JP2020503356A (ja) | 2020-01-30 |
| KR20190103281A (ko) | 2019-09-04 |
| EP3565544A1 (en) | 2019-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273230A (en) | Preparation of carbamoylpyridone-polycyclic compounds | |
| IL258013A (en) | Modulators of kras expression | |
| IL255817B (en) | Synthesis of heterocyclic compounds | |
| EP3265092A4 (en) | Polymorphs of ibrutinib | |
| IL285077A (en) | Compounds for the treatment of cancer | |
| IL259796A (en) | Aza-benzimidazole inhibitors of pad4 | |
| EP3307286A4 (en) | A method of treatment | |
| ZA201700183B (en) | Acetylcholinesterase inhibitors for treatment of dermatological conditions | |
| EP3233783A4 (en) | Improved method for the synthesis of ferric oraganic compounds | |
| GB201521059D0 (en) | Inhibitors of metallo-beta-lactamases | |
| EP3341487B8 (en) | Means and methods for production of organic compounds | |
| GB201609314D0 (en) | Methods of forming compounds | |
| PL3174849T3 (pl) | Synteza pochodnych pirolidyny | |
| IL267277B (en) | Azpan inhibitors of menin–mll interaction | |
| EP3253388A4 (en) | A method of treatment and compounds for use therein | |
| IL267728A (en) | A method for administering nitroxyl-donating compounds | |
| IL263363A (en) | Polymorph of nintedanib | |
| IL266902A (en) | A method for the reduction of oxo-halogen compounds | |
| GB201512635D0 (en) | Uses of therapeutic compounds | |
| AU2015900336A0 (en) | A method of treatment and compounds for use therein | |
| HK1261436A1 (en) | Methods of forming aromatic containing compounds | |
| GB201507937D0 (en) | Compounds for treatment of pancreatic cancer | |
| HK1240493A1 (en) | Methods of treating cancer comprising administering a ppar-gamma agonist | |
| GB201508443D0 (en) | Methods of identifying USP-binding compounds | |
| AU2015902214A0 (en) | A method of treatment |